MacroGenics | MGNX - Market Capitalization

Stock Price
4.25
Daily Change
0.09 2.16%
Monthly
24.63%
Yearly
168.99%
Q2 Forecast
4.16

MacroGenics reported $259.7M in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 364.22B 20.46B May/2026
Amgen USD 189.89B 13.64B Mar/2026
AstraZeneca USD 301.25B 13.1B Mar/2026
Biogen USD 26.9B 1.09B Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Daiichi Sankyo JPY 6.34T 62.51B Dec/2025
Eli Lilly USD 869.02B 146.97B Mar/2026
Genmab DKK 20.48B 1.02B Dec/2025
Geron USD 946M 9M May/2026
Gilead Sciences USD 167.39B 5.6B May/2026
J&J USD 579.15B 78.91B Mar/2026
Karyopharm Therapeutics USD 956M 821M May/2026
MacroGenics USD 102M 4M Dec/2025
Merck USD 297.1B 35.84B Mar/2026
Pfizer USD 147.4B 6.42B May/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Xencor USD 795M 98M May/2026